NM_138761.4:c.369+1621T>G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_138761.4(BAX):​c.369+1621T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.811 in 151,962 control chromosomes in the GnomAD database, including 50,819 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.81 ( 50819 hom., cov: 31)

Consequence

BAX
NM_138761.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.212

Publications

3 publications found
Variant links:
Genes affected
BAX (HGNC:959): (BCL2 associated X, apoptosis regulator) The protein encoded by this gene belongs to the BCL2 protein family. BCL2 family members form hetero- or homodimers and act as anti- or pro-apoptotic regulators that are involved in a wide variety of cellular activities. This protein forms a heterodimer with BCL2, and functions as an apoptotic activator. The association and the ratio of BAX to BCL2 also determines survival or death of a cell following an apoptotic stimulus. This protein is reported to interact with, and increase the opening of, the mitochondrial voltage-dependent anion channel (VDAC), which leads to the loss in membrane potential and the release of cytochrome c. The expression of this gene is regulated by the tumor suppressor P53 and has been shown to be involved in P53-mediated apoptosis. Multiple alternatively spliced transcript variants, which encode different isoforms, have been reported for this gene. [provided by RefSeq, Dec 2019]
BAX Gene-Disease associations (from GenCC):
  • leukemia, acute lymphocytic, susceptibility to, 1
    Inheritance: Unknown Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.925 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_138761.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BAX
NM_138761.4
MANE Select
c.369+1621T>G
intron
N/ANP_620116.1
BAX
NM_001291428.2
c.369+1621T>G
intron
N/ANP_001278357.1
BAX
NM_004324.4
c.369+1621T>G
intron
N/ANP_004315.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BAX
ENST00000345358.12
TSL:1 MANE Select
c.369+1621T>G
intron
N/AENSP00000263262.9
BAX
ENST00000293288.12
TSL:1
c.369+1621T>G
intron
N/AENSP00000293288.8
BAX
ENST00000415969.6
TSL:1
c.369+1621T>G
intron
N/AENSP00000389971.2

Frequencies

GnomAD3 genomes
AF:
0.812
AC:
123234
AN:
151844
Hom.:
50797
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.650
Gnomad AMI
AF:
0.791
Gnomad AMR
AF:
0.811
Gnomad ASJ
AF:
0.897
Gnomad EAS
AF:
0.947
Gnomad SAS
AF:
0.924
Gnomad FIN
AF:
0.909
Gnomad MID
AF:
0.835
Gnomad NFE
AF:
0.872
Gnomad OTH
AF:
0.817
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.811
AC:
123295
AN:
151962
Hom.:
50819
Cov.:
31
AF XY:
0.816
AC XY:
60593
AN XY:
74274
show subpopulations
African (AFR)
AF:
0.650
AC:
26881
AN:
41386
American (AMR)
AF:
0.812
AC:
12373
AN:
15238
Ashkenazi Jewish (ASJ)
AF:
0.897
AC:
3113
AN:
3470
East Asian (EAS)
AF:
0.947
AC:
4915
AN:
5190
South Asian (SAS)
AF:
0.924
AC:
4455
AN:
4820
European-Finnish (FIN)
AF:
0.909
AC:
9594
AN:
10554
Middle Eastern (MID)
AF:
0.840
AC:
247
AN:
294
European-Non Finnish (NFE)
AF:
0.872
AC:
59278
AN:
68000
Other (OTH)
AF:
0.818
AC:
1722
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1114
2228
3343
4457
5571
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
878
1756
2634
3512
4390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.833
Hom.:
14738
Bravo
AF:
0.797
Asia WGS
AF:
0.881
AC:
3064
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.99
DANN
Benign
0.56
PhyloP100
0.21
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1010103; hg19: chr19-49461211; API